'It's definitely a life changer.'
"Reducing the pupil size expands the depth of field or the depth of focus, and that allows you to focus at different ranges naturally," George Waring, principal investigator of a clinical trial for the drug involving 750 participants, toldThe drops aren't the cheapest, but aren't prohibitively expensive, either, at $80 for a 30-day supply.
It isn't a miracle drug, however. Reported side effects include headaches and red eyes. The company is also warning not to use the drops while driving at night. The drops are also mostly effective for middle-aged people. Those above the age of 65 won't see as much of an effect, according toThe value proposition is a matter of convenience — wearing reading glasses can be a pain for millions of people, so ditching them is intriguing.. "I would not need my readers as much, especially on the computer, where I would always need to have them on."
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Should I Get the New COVID Booster?The booster shot, also referred to as a “bivalent” booster, was redesigned in hopes it would more specifically target Omicron subvariants, now the dominant form of COVID in the U.S.
Read more »
Fast-growing cancer cell therapy developer Adicet Bio takes more space - San Francisco Business TimesThe FDA would decide whether its cancer cell therapy is approved, perhaps by the first half of next year.
Read more »
How Apple's AR Glasses will 'kill' the iPhoneApple’s AR glasses have the potential to replace the iPhone as the main computer we use - here’s what it might look like.
Read more »
FDA Approves Oral TYK2 Inhibitor for Treating PsoriasisDeucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, is the first drug in this class to be approved.
Read more »
FDA approves over-the-counter hearing aids to lower costs, increase accessEighty percent of people who would benefit from hearing aids don't wear them, according to the National Institutes of Health. That's because of cost, access and stigma. However, a new move by the FDA may change all of that.
Read more »
Congress hits home stretch renewing FDA user fee programsThe FDA could begin sending furlough notices to staff if lawmakers don't settle on a mechanism for reviewing prescription drugs, medical devices, generic drugs and biosimilars.
Read more »